Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.
|
|
Volume 2 (2005), Issue 6 (June)
- Submicroscopic deletions in an acute myeloid leukemia case with a four-way t(8;11;16;21).
Leuk Res, 29(7): 855-8. [Abstract] [Full-text]
- Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia.
Leuk Res, 29(7): 849-53. [Abstract] [Full-text]
- Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.
J Clin Invest, 115(6): 1503-21. [Abstract] [Full-text]
- Adjuvant docetaxel for node-positive breast cancer.
N Engl J Med, 352(22): 2302-13. [Abstract] [Full-text]
- Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
Clin Cancer Res, 11(11): 4225-33. [Abstract] [Full-text]
- Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001.
Eur J Clin Microbiol Infect Dis, 24(5): 329-33. [Abstract] [Full-text]
- Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
Blood, 105(12): 4573-5. [Abstract] [Full-text]
- Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
Blood, 105(12): 4664-70. [Abstract] [Full-text]
- Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.
Blood, 105(12): 4576-82. [Abstract] [Full-text]
- Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
Blood, 105(12): 4878-84. [Abstract] [Full-text]
- FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model.
Blood, 105(12): 4792-9. [Abstract] [Full-text]
- Occupational exposure to benzene in South Korea.
Chem Biol Interact, 153: 65-74. [Abstract] [Full-text]
- Exposure to benzene and non-Hodgkin lymphoma, an epidemiologic overview and an ongoing case-control study in Shanghai.
Chem Biol Interact, 153: 33-41. [Abstract] [Full-text]
- Review of the literature on benzene exposure and leukemia subtypes.
Chem Biol Interact, 153: 9-21. [Abstract] [Full-text]
- Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung.
Am J Hematol, 79(2): 132-5. [Abstract] [Full-text]
- Ethnicity variables in the incidence rates of leukemias in New Zealand populations: implications for stem-cell transplantation.
Am J Hematol, 79(2): 114-8. [Abstract] [Full-text]
- Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Am J Hematol, 79(2): 136-41. [Abstract] [Full-text]
- Cell apoptosis induced by a synthetic carbazole compound LCY-2-CHO is mediated through activation of caspase and mitochondrial pathways.
Biochem Pharmacol, 70(1): 102-12. [Abstract] [Full-text]
- Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome.
Genes Chromosomes Cancer, 43(4): 383-9. [Abstract] [Full-text]
- An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phase.
Eur J Haematol, 75(1): 73-7. [Abstract] [Full-text]
- Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.
Eur J Haematol, 75(1): 41-6. [Abstract] [Full-text]
- Acquired inv(9): what is its significance?
Cancer Genet Cytogenet, 160(1): 76-8. [Abstract] [Full-text]
- Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11.
Cancer Genet Cytogenet, 160(1): 68-72. [Abstract] [Full-text]
- Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia.
Oncogene, 24(22): 3678-83. [Abstract] [Full-text]
- In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells.
Mol Cancer Ther, 4(6): 885-900. [Abstract] [Full-text]
- Acute myeloid leukemia stem cells.
Ann N Y Acad Sci, 1044: 1-5. [Abstract] [Full-text]
- Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
J Clin Oncol, 23(18): 4179-91. [Abstract] [Full-text]
- Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.
J Clin Oncol, 23(18): 4110-6. [Abstract] [Full-text]
- Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometry.
Cytometry A, 66(1): 71-7. [Abstract] [Full-text]
- Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia.
Oncogene, 24(25): 4129-37. [Abstract] [Full-text]
- Improved detection of minimal acute myeloid leukemia cells by the use of the combined parameters of XE-2100 hematology analyzer.
Cytometry B Clin Cytom, 66(1): 18-24. [Abstract] [Full-text]
- Molecular biomarkers for the study of childhood leukemia.
Toxicol Appl Pharmacol, 206(2): 237-45. [Abstract] [Full-text]
- Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine.
Blood, 106(1): 318-27. [Abstract] [Full-text]
- The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
Blood, 106(1): 345-52. [Abstract] [Full-text]
- AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations.
Blood, 106(1): 265-73. [Abstract] [Full-text]
- Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.
Blood, 106(1): 27-34. [Abstract] [Full-text]
- Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia.
J Lab Clin Med, 145(6): 295-304. [Abstract] [Full-text]
- Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6.
Leuk Res, 29(8): 893-9. [Abstract] [Full-text]
- Acute leukemia during pregnancy: a report on 37 patients and a review of the literature.
Cancer, 104(1): 110-7. [Abstract] [Full-text]
- Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Cancer, 104(1): 101-9. [Abstract] [Full-text]
- Identification of a novel HLA-DRB1 allele (HLA-DRB1*111902*).
Tissue Antigens, 66(1): 67-8. [Abstract] [Full-text]
- Lifestyle factors and the risk of adult leukemia in Canada.
Cancer Causes Control, 16(5): 489-500. [Abstract] [Full-text]
- Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.
FASEB J, 19(9): 1067-77. [Abstract] [Full-text]
- Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts.
BMC Cancer, 5(1): 60. [Abstract] [Full-text]
- Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7.
Pediatr Blood Cancer, 45(2): 212-6. [Abstract] [Full-text]
- Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.
Mol Cell Biol, 25(14): 5869-79. [Abstract] [Full-text]
- Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay.
Cancer Chemother Pharmacol, 56(3): 322-7. [Abstract] [Full-text]
© 2004-2012 Acute Myeloid Leukemia Research Today. All Rights Reserved.
|
|